Elbonix 25mg Tablets 28s (Eltrombopag)
Overview
| Manufacturer | Novartis Pharma Pakistan |
| Active Ingredients | Eltrombopag Olamine |
| Medicine Strength | 25mg per Tablet |
| Formulation | Film-Coated Tablets |
| Requires Prescription? | Yes (Hematologist prescription required) |
| Generics | Eltrombopag |
Elbonix Ingredients and Usage
Chronic immune thrombocytopenia in refractory patients
Thrombocytopenia in chronic hepatitis C patients
Severe aplastic anemia treatment
Patients who are splenectomized or non-splenectomized
How Does Elbonix Work?
TPO Receptor Binding: Activates human thrombopoietin receptor
Megakaryocyte Stimulation: Promotes proliferation and differentiation
Platelet Production: Increases platelet counts in circulation
Selective Action: Works independently of endogenous thrombopoietin
Elbonix Side Effects and Warnings
Serious Considerations
Hepatotoxicity: Regular liver function monitoring required
Bone Marrow Fibrosis: Risk of increased reticulin formation
Thrombotic Risk: Increased risk of blood clots with high platelet counts
Cataract Development: Regular ophthalmological examinations needed
Drug Interactions: Chelates with polyvalent cations affecting absorption
Elbonix Storage Conditions
Store at room temperature below 30°C
Keep in original packaging protected from moisture
Protect from light and excessive heat
Keep out of reach of children
Do not use after expiration date
Customer Reviews
No reviews yet. Be the first to review this product!
Login to write a review